Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Aspira Pathlab & Diagnostics Ltd
Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Ltd Share Price

  • Sector: Healthcare (Small Cap)
  • Volume: 736
Jul 10, 2025 Closed
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹53.50
₹1.04 (1.98%)
51.42Low
Today’s Performance
53.50High
29.20Low
52 Week’s Performance
106.78High

bt_logoStock Performance

  • 1 Day1.98%
  • 1 Week-5.85%
  • 1 Month-3.74%
  • 3 Months-20.44%
  • 6 Months-29.50%
  • 1 Year65.38%
  • 3 Years-0.53%
  • 5 Years12.98%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.50
  • 52-Week Low (₹)29.20
  • 52-Week High (₹)106.78
  • Price-to-Book (X)*4.44
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*26.63
  • Earnings Per Share (₹)1.97
  • Market Cap (₹ Cr.)*54.00
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Shashi Tharoor Slams Indira’s Emergency Era | Congress Retorts: ‘Bird Turning Into Parrot?’3:11Shashi Tharoor Slams Indira’s Emergency Era | Congress Retorts: ‘Bird Turning Into Parrot?’
Devina Mehra’s Investment Masterclass: SIPs, PMS, Mutual Funds, Or DIY? What Should You Choose?3:51Devina Mehra’s Investment Masterclass: SIPs, PMS, Mutual Funds, Or DIY? What Should You Choose?
Can Desilting Triple Farm Yields? Piyush Goyal Outlines Roadmap For Agri Growth2:09Can Desilting Triple Farm Yields? Piyush Goyal Outlines Roadmap For Agri Growth
Devina Mehra Message To F&O Traders Amid Jane Street Crisis3:06Devina Mehra Message To F&O Traders Amid Jane Street Crisis
Vice President Jagdeep Dhankhar: Bharat Leads With Ethics, Economy, And Ecology4:34Vice President Jagdeep Dhankhar: Bharat Leads With Ethics, Economy, And Ecology
From Innovation To Atmanirbharta: Piyush Goyal’s Roadmap For Energy Efficiency3:48From Innovation To Atmanirbharta: Piyush Goyal’s Roadmap For Energy Efficiency
Inside NVIDIA's RTX 50 Series & Blackwell AI Showcase2:01Inside NVIDIA's RTX 50 Series & Blackwell AI Showcase
Exclusive: Karnataka CM Denies His Image Has Been Hit After Cricket Stampede, Corruption Charges3:57Exclusive: Karnataka CM Denies His Image Has Been Hit After Cricket Stampede, Corruption Charges
BTS - Driving The Comeback20:19BTS - Driving The Comeback
Indian Astronaut Shubhanshu Shukla Carries ISRO Experiments to ISS | Proud Moment for India2:11Indian Astronaut Shubhanshu Shukla Carries ISRO Experiments to ISS | Proud Moment for India
View more

bt_logoFAQ's

What was Aspira Pathlab & Diagnostics Ltd share price previously?
Aspira Pathlab & Diagnostics Ltd share price was up by 1.98% from the previous closing price of ₹52.46.
Who are peers of Aspira Pathlab & Diagnostics Ltd?
The peers of Aspira Pathlab & Diagnostics Ltd are Max Healthcare Institute Ltd, Apollo Hospitals Enterprise Ltd, Fortis Healthcare Ltd, Narayana Hrudayalaya Ltd, Global Health Ltd, Aster DM Healthcare Ltd, Krishna Institute of Medical Sciences Ltd.
Who is/are the promoter/promoters of Aspira Pathlab & Diagnostics Ltd?
The promotor/promotors of Aspira Pathlab & Diagnostics Ltd are Pankaj Jashwant Shah, Mangala Radha Krishnan Prabhu, Haseeb Drabu, Nikunj Mange, Manas Mengar, Krupali Shah.
What has been 52-week high of Aspira Pathlab & Diagnostics Ltd stocks?
The highest price of Aspira Pathlab & Diagnostics Ltd stock is ₹106.78 in the last 52-week.
What is the share price of Aspira Pathlab & Diagnostics Ltd (ASPIRA) today on BSE?
As on Jul 10, 2025 Aspira Pathlab & Diagnostics Ltd (ASPIRA)’s share price on BSE is Rs 53.5
What is the market cap of Aspira Pathlab & Diagnostics Ltd (ASPIRA)?
The current market capitalisation of Aspira Pathlab & Diagnostics Ltd (ASPIRA) is 54.00 crores
What is Aspira Pathlab & Diagnostics Ltd Share symbol?
The symbol of Aspira Pathlab & Diagnostics Ltd is .
What is the PE ratio of Aspira Pathlab & Diagnostics Ltd (ASPIRA)?
The current PE ratio of Aspira Pathlab & Diagnostics Ltd (ASPIRA) is 26.63.
What is the PB ratio of Aspira Pathlab & Diagnostics Ltd (ASPIRA)?
The current PB ratio of Aspira Pathlab & Diagnostics Ltd (ASPIRA) is 4.44.
Today’s High & Low share prices of Aspira Pathlab & Diagnostics Ltd (ASPIRA) on BSE?
Today, the share price of Aspira Pathlab & Diagnostics Ltd (ASPIRA) on BSE touched a high of Rs 53.5 and a low of Rs 51.42
What price did Aspira Pathlab & Diagnostics Ltd (ASPIRA) shares open on the BSE today?
On BSE, the share price of Aspira Pathlab & Diagnostics Ltd (ASPIRA) opened at Rs 52.46
What is the 52-week high of Aspira Pathlab & Diagnostics Ltd (ASPIRA)?
The 52-week high price of Aspira Pathlab & Diagnostics Ltd (ASPIRA) is Rs 106.78
What is the 52-week low of Aspira Pathlab & Diagnostics Ltd (ASPIRA)?
The 52-week low price of Aspira Pathlab & Diagnostics Ltd (ASPIRA) is Rs 29.20

bt_logoAbout Aspira Pathlab

Aspira Pathlab & Diagnostics Ltd, incorporated in the year 1973, has its registered office in Flat No. 2 RD Shah Building, Shraddanand Road Ghatkopar(W), Mumbai, Maharashtra, 400086, 91-22-71975756/5656. The main industry in which Aspira Pathlab & Diagnostics Ltd operates is Healthcare.

Auditor/Auditors for Aspira Pathlab & Diagnostics Ltd is/are P Khetan & Co/Sarda Soni Associates LLP. In the main management, Haseeb Drabu is chairman and Krupali Shah is the company secretary for Aspira Pathlab & Diagnostics Ltd.

  • PJS
    Pankaj Jashwant ShahManaging Director & CEO
  • MRKP
    Mangala Radha Krishnan PrabhuIndependent Director
  • HD
    Haseeb DrabuChairman & Independent Directo
  • NM
    Nikunj MangeExecutive Director
  • MM
    Manas MengarIndependent Director
  • KS
    Krupali ShahCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.